Psyched: Steve Cohen's New Biopharma Bet, California Gov. Authorizes Medical Psychedelics & More
Psyched: Steve Cohen's New Biopharma Bet, California Gov. Authorizes Medical Psychedelics & More
Psyched：史蒂夫·科恩的新生物製藥賭注，加利福尼亞州州長授權醫用迷幻藥等
Steve Cohen Keeps Betting On Biopharma With Purchase Of 119M+ Bionomics Shares
史蒂夫·科恩繼續押注生物製藥，購買了1.19億多股生物經濟學股票
NY Mets owner Steve Cohen has bought as many as 119,092,680 ordinary shares of clinical-stage biopharmaceutical company Bionomics Limited (NASDAQ:BNOX) through his Point72 asset management firm, again showing support for the biopharma sector (See recent buy of Cybin (NYSE: CYBN) shares.)
紐約大都會隊老闆史蒂夫·科恩通過其Point72資產管理公司購買了臨床階段的生物製藥公司Bionomics Limited（納斯達克股票代碼：BNOX）的多達119,092,680股普通股，再次表示對生物製藥行業的支持（見最近對Cybin（紐約證券交易所代碼：CYBN）股票的買入。）
The Australia-based company currently trades on the Nasdaq and in the Frankfurt Stock Exchange (Fra) by means of American Depositary Shares (ADS) and recently announced its delisting intentions from the Australian Securities Exchange (ASX) following a U.S.-focused transformation plan. Read more HERE.
這家總部位於澳大利亞的公司目前通過美國存托股票（ADS）在納斯達克和法蘭克福證券交易所（Fra）上市，並根據一項以美國爲重點的轉型計劃，最近宣佈打算從澳大利亞證券交易所（ASX）退市。點擊此處閱讀更多。
Gov Newsom Green...
州長 ...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。